Recombinant Edwardsiella ictaluri NADH-quinone oxidoreductase subunit K (nuoK), also known as NDH-1 subunit K, is a full-length recombinant protein derived from the bacterium Edwardsiella ictaluri. It is a critical component of bacterial Complex I (NADH dehydrogenase I), a multi-subunit enzyme in the electron transport chain that transfers electrons from NADH to quinones while pumping protons across the membrane, contributing to ATP synthesis .
This recombinant protein is engineered with an N-terminal histidine (His) tag for purification and is expressed in Escherichia coli. Its primary applications include biochemical research, vaccine development, and studies on bacterial pathogenesis .
In Salmonella, Complex I activity is measured via:
dNADH-oxidase activity: Depends on endogenous quinone pools.
dNADH-DB activity: Uses exogenous ubiquinone analogs (e.g., DB).
dNADH-K₃Fe(CN)₆ reductase activity: Assesses dehydrogenase domain function .
For Edwardsiella ictaluri nuoK, similar assays could evaluate its role in electron transfer, though experimental data remain pending.
Edwardsiella ictaluri is a fish pathogen causing enteric septicemia of catfish (ESC). While nuoK itself is not directly implicated in virulence, its study contributes to understanding bacterial energy metabolism under stress conditions (e.g., low pH, phosphate limitation) .
Recombinant proteins like nuoK may serve as antigens or components in vaccine vectors. For example, Edwardsiella’s asdA gene deletion paired with balanced-lethal systems has been explored for live-attenuated vaccine platforms .
Antimicrobial Targeting: Inhibiting Complex I activity could disrupt bacterial respiration. Capsaicin derivatives (e.g., capsaicin-40) show promise as NDH-1 inhibitors .
Structural Biology: Crystallographic studies on nuoK could reveal quinone-binding motifs, aiding drug design.
Host-Pathogen Interactions: Investigating nuoK’s role in Edwardsiella’s adaptation to host environments (e.g., macrophage phagosomes) .
KEGG: eic:NT01EI_2670
STRING: 634503.NT01EI_2670
Edwardsiella ictaluri is a gram-negative bacterium belonging to the Enterobacteriaceae family. It is the causative agent of enteric septicemia of catfish (ESC), a fatal disease that significantly impacts the catfish aquaculture industry. ESC costs the industry millions of dollars in losses annually, with estimates ranging from $50-80 million . E. ictaluri's significance in research stems from its ability to replicate intracellularly within catfish head-kidney-derived macrophages (HKDM) and its sophisticated mechanisms for evading host immune responses .
The bacterium employs a Type III Secretion System (T3SS) that is crucial for both its virulence and intracellular replication capabilities. This system translocates effectors from the Edwardsiella containing vacuole (ECV) through the bacterial cell wall and vacuolar membrane directly to the host cytoplasm . Understanding the molecular mechanisms behind E. ictaluri's pathogenicity is essential for developing effective control strategies for ESC.
The recombinant version of E. ictaluri nuoK protein described in the literature features a full-length construct (amino acids 1-100) with an N-terminal histidine tag . This His-tag modification facilitates protein purification through metal affinity chromatography but represents a structural difference from the native protein.
| Feature | Native nuoK | Recombinant nuoK |
|---|---|---|
| Length | 100 amino acids | 100 amino acids (plus His-tag) |
| N-terminus | Natural N-terminus | His-tag modification |
| Expression system | E. ictaluri | E. coli |
| Cellular localization | Membrane-embedded | Depends on expression conditions |
| Post-translational modifications | Potentially present | May differ from native protein |
When designing experiments using recombinant nuoK, researchers should consider how the His-tag might affect protein folding, membrane insertion, or interactions with other proteins. While the tag is essential for purification, it may influence structure-function relationships in experimental settings .
Based on documented methods, E. coli expression systems have been successfully employed for recombinant production of E. ictaluri nuoK protein . When designing an expression strategy, researchers should consider the following methodological approaches:
Expression System Selection:
BL21(DE3) or similar E. coli strains designed for membrane protein expression
Expression vectors with tightly controlled inducible promoters (T7, tac, or arabinose-inducible systems)
Consideration of codon optimization for heterologous expression
Optimization Parameters:
Induction temperature (often lowered to 16-25°C for membrane proteins)
Inducer concentration
Duration of induction
Media composition (potentially including osmolytes or membrane stabilizers)
For membrane proteins like nuoK, expression conditions that are too aggressive often lead to inclusion body formation. A balanced approach with moderate induction at lower temperatures may yield better results for obtaining properly folded protein .
The purification and storage of recombinant nuoK requires careful consideration of its membrane protein characteristics. Based on established protocols for similar proteins and specific information about nuoK, the following methodological approach is recommended:
Purification Protocol:
Cell lysis: Gentle lysis using methods suitable for membrane proteins (e.g., French press, sonication with mild detergents)
Membrane isolation: Ultracentrifugation to separate membrane fractions
Solubilization: Use of appropriate detergents (DDM, LDAO, or other mild detergents)
IMAC purification: Utilizing the His-tag for metal affinity chromatography
Size exclusion chromatography: For further purification and buffer exchange
Storage Recommendations:
For reconstituted protein, add 5-50% glycerol (final concentration)
The protein can be maintained as a lyophilized powder for long-term storage
For working stocks, store aliquots at 4°C for up to one week to minimize degradation from repeated freeze-thaw cycles .
The reconstitution of lyophilized recombinant nuoK protein requires careful handling to preserve structure and function. The following methodological approach is recommended based on documented protocols:
Briefly centrifuge the vial prior to opening to bring contents to the bottom
Reconstitute the protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL
Add glycerol to a final concentration of 5-50% (with 50% being the default recommendation) for long-term storage
Prepare multiple small-volume aliquots to minimize freeze-thaw cycles
For functional studies, researchers may need to consider reconstitution into artificial membrane systems such as liposomes or nanodiscs to better mimic the native membrane environment of nuoK. This is particularly important for functional assays assessing electron transport or proton translocation activities.
While direct experimental evidence linking nuoK specifically to E. ictaluri pathogenesis mechanisms is not extensively documented in the provided literature, we can formulate research hypotheses based on the known pathogenic mechanisms of E. ictaluri and the role of respiratory chain components in bacterial virulence:
E. ictaluri evades host immune responses through multiple mechanisms, including:
As a component of the bacterial respiratory chain, nuoK might contribute to these processes by:
Supporting energy production necessary for intracellular survival and replication
Contributing to maintenance of membrane potential, which can affect various virulence mechanisms
Potentially playing a role in adaptation to the intracellular environment of macrophages, where nutrient availability and oxygen tension differ from extracellular conditions
Methodologically, researchers investigating this relationship could design experiments using nuoK knockout mutants or strains with regulated expression of nuoK to assess impacts on:
The potential of nuoK as a vaccine target can be analyzed in the context of ongoing vaccine development efforts against E. ictaluri. Current approaches include:
Live recombinant attenuated Edwardsiella vaccines (RAEV) that display:
An EseK knockout strain that provides catfish fingerlings with protection against subsequent wild-type exposure
The potential of nuoK as a vaccine target depends on several factors:
| Factor | Consideration for nuoK |
|---|---|
| Immunogenicity | As a membrane protein, nuoK may have limited exposure to the immune system |
| Conservation | If highly conserved across E. ictaluri strains, could provide broad protection |
| Essentiality | If essential for survival, mutations would be less likely to emerge |
| Accessibility | Membrane localization may limit accessibility to antibodies |
Methodologically, researchers could:
Evaluate immune responses to recombinant nuoK protein in fish models
Test protective efficacy of nuoK-based subunit vaccines
Consider including nuoK in broader multi-antigen vaccine approaches
Explore whether nuoK could be genetically modified in live attenuated vaccines
Understanding the interactions between nuoK and other bacterial proteins requires sophisticated experimental approaches suitable for membrane proteins. Recommended methodological approaches include:
In vitro Interaction Studies:
Pull-down assays using His-tagged nuoK as bait
Bacterial two-hybrid systems adapted for membrane proteins
Cross-linking studies followed by mass spectrometry
Surface plasmon resonance with reconstituted proteins
Structural Studies:
Cryo-electron microscopy of the entire NADH-quinone oxidoreductase complex
X-ray crystallography (challenging for membrane proteins)
NMR studies of specific domains or interactions
In vivo Approaches:
Fluorescence resonance energy transfer (FRET) with tagged proteins
Suppressor mutation analysis
Co-immunoprecipitation from bacterial lysates
Genetic approaches using interacting-domain mapping
When designing these experiments, researchers should consider the hydrophobic nature of nuoK and ensure that experimental conditions maintain its native conformation, potentially through the use of appropriate detergents or membrane mimetics.
Membrane proteins like nuoK present several experimental challenges. Here are methodological approaches to address common issues:
For efficient troubleshooting, researchers should implement systematic approaches, changing one variable at a time and documenting outcomes carefully. Small-scale expression trials can be valuable for optimizing conditions before scaling up production.
Validating that purified recombinant nuoK maintains its native structural and functional properties is critical for experimental reliability. Recommended methodological approaches include:
Structural Integrity Assessment:
Circular dichroism spectroscopy to confirm secondary structure
Size exclusion chromatography to verify monodispersity
Limited proteolysis to assess proper folding
Thermal shift assays to evaluate stability
Functional Analysis:
Reconstitution into proteoliposomes for proton pumping assays
NADH oxidation activity measurements in reconstituted systems
Membrane potential measurements using fluorescent probes
Electron transfer assays with artificial electron acceptors
Interaction Studies:
Binding assays with known interaction partners
Assembly into partial or complete complex I structures
Detergent micelle incorporation efficiency
When validating recombinant nuoK, researchers should compare results with known properties of the native protein or homologous proteins from related species when direct data on E. ictaluri nuoK is limited.
Genetic Studies:
Clean deletion mutants with confirmed genotype
Complementation strains to verify phenotype restoration
Point mutations in key residues rather than full deletions
Inducible expression systems to control timing and level of expression
Pathogenesis Models:
Wild-type E. ictaluri strains as positive controls
Known attenuated strains as reference points
Mutations in unrelated genes to control for general fitness effects
Host cell controls (uninfected, infected with other pathogens)
Specific for Macrophage Interaction Studies:
Controls for M1 phenotype induction independent of nuoK
When examining nuoK's potential contribution to immune evasion, researchers should pay special attention to the CD40 pathway and T cell responses, as E. ictaluri is known to manipulate these systems during infection .
While traditional biochemical and molecular biology approaches have provided valuable insights into membrane proteins like nuoK, emerging high-throughput methodologies offer new opportunities for accelerated discovery. Researchers should consider:
Systems Biology Approaches:
Transcriptomics to identify co-regulated genes under different conditions
Proteomics to map the complete interactome of nuoK
Metabolomics to assess the impact of nuoK manipulation on bacterial metabolism
High-Throughput Structural Studies:
Cryo-EM for structure determination at near-atomic resolution
Hydrogen-deuterium exchange mass spectrometry for dynamic structural information
Deep mutational scanning to map functional residues
Advanced Computational Methods:
Molecular dynamics simulations of nuoK in membrane environments
Machine learning approaches to predict functional impacts of mutations
Integrative modeling combining multiple experimental data types
These approaches can complement traditional methods and potentially identify unexpected roles for nuoK in E. ictaluri biology and pathogenesis that might be missed by hypothesis-driven research alone.
Given the essential role of the respiratory chain in bacterial energy metabolism, nuoK and related components represent potential targets for novel antimicrobial strategies. Researchers exploring this direction should consider:
Target Validation Approaches:
Conditional knockdown strains to confirm essentiality
Fitness studies under different growth conditions
Assessment of metabolic bypass pathways
Inhibitor Discovery Strategies:
Structure-based virtual screening for binding pocket identification
Fragment-based drug discovery approaches
Phenotypic screening with target deconvolution
Therapeutic Index Considerations:
Comparison with homologous proteins in host species
Selectivity assessment against related bacterial species
Evaluation of resistance development potential